baber/WOPTO huggingface dataset:
Patent JP-H10509236-A (JP)
Title: パイプライン移動体
IPC: B62D57/024
Filed: 1996-05-21
Abstract: (57)【要約】
パイプライン内で少なくとも１つの作業を行うパイプ内移動体。この移動体はサスペンション・ユニット（１７）によって相互連結されていてパイプ湾曲部を通して蛇状の動きを行えるモジュール（１１−１６）の列を包含する。移動体のモジュール列はそれ自体の内蔵電源と、それぞれのモジュール内の駆動機構とを有する。検出器モジュール（１４）が磁界情報を用いて引込み管接合部の存在を決定し、マニピュレータ・モジュール（１３）が接合部のところでの所望の作業を容易にする回転運度を行わせながらパイプライン内に移動体を一時的にくさび止めすることができる。この所望作業には、適当なモジュールを用いての主管の穿孔および引込みパイプの主管への溶接を含み得る。代表的には磁界発生器を含む遠隔操作プローブを用いて移動体による引込み管接合部の位置決めを助けることができる。
Patent JP-2000508535-A (JP)
Title: 固定化アリイナーゼおよびアリシンの連続生産
IPC: A23L29/00
Filed: 1997-04-14
Abstract: (57)【要約】
アリイナーゼを化学的に、物理的に、生物学的に固定化した固定化にんにくアリイナーゼは、アリシンの連続生産法として有用である。方法は、基質としてアリイン溶液を該固定化にんにくアリイナーゼを含むカラムに添加し、精製アリシンを回収することから成る。精製アリシンは食品添加物や、ウイルス、細菌、菌および寄生虫の感染、高レベルのコレステロールおよび血液脂質、高血圧および血栓症の治療のための医薬品組成物の調製に使用するものである。
Patent JP-2000500659-A (JP)
Title: 除草剤耐性イネ
IPC: A01H5/10
Filed: 1997-04-28
Abstract: (57)【要約】
植物のアセトヒドロキシ酸シンターゼ(AHAS)を通常阻害する除草剤に対する耐性に関して独立しているが相乗的作用を奏する２つの機構を有するイネ植物を開示する。両方の耐性機構を有する植物の除草剤耐性は、２種の耐性の単なる組み合わせから期待されるものより実質的に大きい。２つの耐性機構の第一は、完全には解明されていない代謝経路であるが、それ自体変異AHAS酵素に関与しないものである。第二の耐性機構は、変異AHAS酵素であり、インビボ及びインビトロアッセイの両方で、酵素を通常阻害する除草剤レベルに対する直接的耐性を示す酵素である。レッドライスを抑制するばかりでなく、多くのAHAS阻害除草剤は、田圃に共存する雑草をも効果的に抑制する。これらの除草剤のいくつかは残留活性を有するため、処理により、現存する雑草及び後に発芽する雑草の両方とも抑制する。イネに使用するための、レッドライスを含む幅広い種の雑草に対する残留活性を有する除草剤は、今のところ入手不可能である。レッドライス及び他の雑草に対する効果的な残留活性により、米生産者は今や、現在使用されているものより優れた雑草抑制システムを入手する。
Patent JP-2001509064-A (JP)
Title: 真皮、皮下、および声帯組織欠損の増大および修復
IPC: A61K35/12
Filed: 1998-02-20
Abstract: (57)【要約】
本発明は、結合組織由来の自系培養繊維芽細胞または固有層もしくは脂肪細胞由来の真皮もしくは筋膜固有層組織繊維芽細胞の注入または直接的外科的配置による皮膚、皮下または声帯組織の長期増大および／または修復のための方法である。皮膚欠損の増強および／または修復に用いられる繊維芽細胞培養は、結合組織、皮膚および／または筋膜繊維芽細胞から誘導される。さらに、患者自身の血清中の無血清培地中での培養繊維芽細胞固有層組織または脂肪細胞の後期継代接種による、培養細胞が潜在的免疫原性の血清誘導タンパク質を実質的に含有しないようにさせる方法。
Patent JP-2002512576-A (JP)
Title: 車両用装置
IPC: B62D9/00
Filed: 1998-03-26
Abstract: (57)【要約】
本発明は、車両を駆動する駆動手段（３２、２１０）と車両の方向を変換するステアリング手段（１８、２１２）とを備えた車両の差動装置用の装置に関し、その差動装置（２６）は１個の入力駆動軸（２４、１４６）と、車両の駆動手段（３２、２１０）と連結する２個の出力軸（２８、３０）と、差動油の流れを生成する少なくとも１個の油圧ポンプ（３４、９０、１５２、１５４）と、油圧ポンプと接続し差動装置（２６）に配置され出力軸間に回転速度の差を生じさせる少なくとも１個の油圧モータ（７０）とを有する。本発明は、ステアリング手段のステアリングの方向と車両の走行速度に対応して油圧ポンプと油圧モータとの間を流れる作動油の流れを調整可能な手段（３６、４８、１５６、１５８、２１４）を特徴とする。
Patent JP-2001519906-A (JP)
Title: 連続式環状クロマトグラフィー装置
IPC: G01N30/58
Filed: 1998-03-25
Abstract: (57)【要約】
本発明は、シリンダケーシングの形に形成された粒子層と、液体原材料の少なくとも一つの供給位置とを有する連続式環状クロマトグラフィー装置に関する。上記の粒子層および供給位置は、互いに相対運動をするものである。本発明は、特に粒子層材料を搬送するために、粒子層へのアクセスを可能とする少なくとも一つの開口（１２，３２）が粒子層室(particle bed chamber)の下端に設けられていることを特徴としている。
Patent JP-2002514077-A (JP)
IPC: C12N15/81
Filed: 1998-04-14
Abstract: The present invention provides for a yeast cell comprising at least two copies of a desired gene integrated into its chromosomal genome, wherein said genome comprises at least two DNA domains suitable for integration of one or more copies of said desired gene, which domains share substantial sequence homology and are non-ribosomal RNA encoding DNA domains, and wherein at least two of said substantially homologous non-ribosomal RNA encoding domains DNA domains have at least one copy of the said desired gene integrated. The invention also provides methods for making yeast cells according to the invention, as well as the use thereof for making a protein, a peptide or metabolite.
Patent JP-2002501410-A (JP)
Title: 放射性の医療用縫合糸並びにその製法
IPC: A61N5/10
Filed: 1998-04-09
Abstract: (57)【要約】
内膜増殖反応を抑制するための放射性縫合糸は、針と放射性ベータ放射元素を具備する縫合糸材料とから構成されている。この放射性元素は、縫合糸材料の有機的基質に望ましくは化学結合されている。放射性縫合材料は0.0002uCi/cmを超えるベータ線を発生することが望ましい。放射性縫合糸を製造する第一の望ましい方法は、密封された反応室中に縫合針と縫合糸材料を装入する工程を含んでいる。縫合糸が反応室中に装入されると、イオン化されたベータ線放射元素、望ましくはイオン化された三重水素、が室内へ導入される。室内ではエントロピー交換過程が始まり、ベータ線放射元素が有機縫合材料中の水素分子と交換される。望みの水準の三重水素又は他のベータ線放射元素が縫合材料と結合すると、反応室は洗浄処理される。縫合糸は洗浄、乾燥されて、反応室から取り出されてから包装される。もう一つの態様においては、放射性縫合糸は有機ポリプロピレン材料から製造される。ベータ線放射元素、望ましくは三重水素は、直接有機ポリプロピレン材料の基質に結合させられる。放射性となったポリプロピレン材料は縫合糸用の糸に押し出し加工され、縫合針に取り付けられ、出荷や後の利用のために包装される。本発明の方法で必要条件とされるわけではないが、有機ポリプロピレン材料の望ましい実施態様は炭素12で構成される。
Patent JP-2001523251-A (JP)
IPC: A61P15/18
Filed: 1998-04-27
Abstract: This invention pertains to the discovery that condensation polymers of an aldehyde and aromatic sulfonic acids and fractions thereof, such as formaldehyde naphthalenesulfonic acid condensation polymers, can prevent pregnancy in an individual.
Patent JP-2001525110-A (JP)
Title: グレア制御を有する自動車ランプ
IPC: F21S8/10
Filed: 1998-04-28
Abstract: (57)【要約】
自動車のヘッドランプに使われる、管状の部分を持ったランプ外囲容器を含むランプカプセルである。電気エネルギーにより賦活されたときに光を放射するための、間隔を開けられて配置された、第１と第２のフィラメントがランプ外囲容器内に取り付けられている。ランプカプセルはさらに、１つ以上の光を減衰する軸方向の縞をランプ外囲容器上に有する。軸方向の縞は、第１のフィラメントにより放射され、第２のフィラメントにより反射された光を遮るために、ランプ外囲容器に配置される。ランプカプセルはさらに、ランプ外囲容器の透明な領域の上部と下部の境を画定するために、外囲容器の両端またはその近くに、光を減衰するリングを有することもできる。フィラメントの支持構造は、光の遮りとそれた反射を制限するために、第１と第２フィラメントを含む平面に配置される支持導線を備えることもできる。
Patent JP-2001526799-A (JP)
IPC: G10D3/04
Filed: 1998-04-29
Abstract: An improved capo for use with various stringed instruments is provided. The capo comprises a frame having a top arm to contact the strings and a side arm, with a jaw member and a lever member both pivotally attached to the side arm. The jaw member contacts the back of the instrument neck when the capo is closed. Mounted on the lever member is a flexible member, having a follower surface that contacts the lower surface of the jaw member during the closing action of the capo and while the capo is closed. An adjustable stop passes through the lever member such that one end of the adjustable stop contacts the lower surface of the flexible member to urge the follower surface into contact with the lower surface of the jaw member. The improved capo of the invention is easier to attach and remove than capos of the prior art, maintains better alignment between the jaw member and the lever member, is less subject to frictional wear, and optimizes the degree of dropoff along the entire useable range of the capo.
Patent JP-2002512518-A (JP)
Title: 初期肝発生用タンパク質をコードする遺伝子並びにその肝疾患の診断及び治療における使用
IPC: A61P35/00
Filed: 1998-04-30
Abstract: (57)【要約】
単離され、配列決定された初期発生段階特異的な肝タンパク質及びそれをコードする遺伝子を提供するものであり、これらの遺伝子及びタンパク質は種々様々な肝疾患及び他の病気の診断及び／治療に利用できる。本発明において同定され、単離されたタンパク質としては、elf １〜３、liyor-１(145)、pk、タンパク質106及びpraja-１として知られているタンパク質が、これらのタンパク質及びその他のタンパク質をコードする核酸配列と共に挙げられ、またこれらのタンパク質から誘導されるペプチドに対して抗体を生成させ得る。本発明の初期発生肝タンパク質は胚形成中に生じることから、肝臓及びその他の臓器が未分化状態から分化した状態への移行状態にある場合には、これらのタンパク質は組織の分化に関わり、従って種々の肝疾患及びその他の病気、例えば発癌及び組織修復に関連する病気を診断及び治療する方法に利用できる。従って、本発明の単離された初期発生肝タンパク質は、末期肝硬変から肝細胞癌までの一連の病気及びその他の多数の病気の診断及び治療に密接な関わりをもつ。
Patent MD-20070295-A (MD)
Title: Bitumen melting plant
Inventor: LUPU MIHAI
IPC: B03B9/02
Filed: 2007-10-31
Abstract: The invention relates to the field of waste processing, particularly to roofing waste bitumen melting and can be used for obtaining bitumen from waste.The bitumen melting plant consists of a melting chamber, a system for introduction therein of hot gases, a furnace for incineration of the mixture of substances, a volatile matters removal system, joining the melting chamber and the furnace, as well as a gas cleaning device.
Patent MX-157315-A (MX)
Inventor: SCHWINN HORST
IPC: A61K35/16
Filed: 1982-01-20
Abstract: A process for purifying liquids containing blood clotting factors by adsorption of the factors on mineral adsorbents such as calcium phosphate, aluminum hydroxide gel, barium sulfate or hydroxylapatite in the presence of calcium ions followed by elution is described.
Patent MX-157902-A (MX)
Inventor: HARTMANN LUDWIG ALBERT
IPC: C07D211/26
Filed: 1983-10-06
Abstract: A 3- or 4-halo-2-pyridone compound of the formula: <CHEM> in which X<4> is halogen (preferably bromine or chlorine) is a useful chemical intermediate in the synthesis of 2-halo-5-methylpyridines themselves useful in the preparation of, for example, 4-(5-halomethyl-2-pyridyloxy)phenoxy herbicides.
Patent NZ-202841-A (NZ)
Title: Conversion of harmonic and dc power to nominal ac grid frequency power
Inventor: SUELZLE L R
IPC: H02M7/797
Filed: 1982-12-17
Abstract: An electrical power convbrsion system for connecting an input source (11) to an a.c. electric power generation grid (13), such as a public utility, including means (27, 26) for absorbing power from the input source (11) and for converting it to power at the nominal frequency, f0, of the grid (13), and further including means (27, 26) for absorbing power from the grid (13), at frequencies above and below f0, and converting it to power at f0.
Patent NZ-209891-A (NZ)
Title: Production of a collapsible bag; liquid passage conduit heat sealed to bag
Inventor: BOONE D C
IPC: B65D83/00
Filed: 1984-10-16
Abstract: A collapsible container 10 comprising a flexible bag including a spot 20 having an opening through which liquid is fed into and dispensed from the bag, and liquid passage means 30 inside of the bag in liquid communication with the spout opening for aiding in the dispensing of liquid from the bag. The liquid passage means is preferably integral with a wall of the bag but may be a separately formed elongate web heat sealed into the bag on making the bag.
Patent NZ-220546-A (NZ)
Title: Benzothiophene- and benzofuran- amides and compositions
Inventor: DUBROEUCQ M-C
IPC: C07D307/79
Filed: 1987-06-03
Abstract: Compounds of formula:   <IMAGE>   in which R1 and R2 are each alkyl, cycloalkyl or phenyl, or NR1R2=piperidine, Ar is optionally substituted phenyl or thienyl, and X< is one of the following linkages:   <IMAGE>  are useful as anxiolytic, antianginal and immunomodulatory agents. They may be made by reaction of an amine with the corresponding acid chloride.
Patent NZ-237706-A (NZ)
Title: Immunoassay procedure for gonadotropal alpha peptide chain
Inventor: CLOUGH KATHLEEN M
IPC: G01N33/50
Filed: 1991-04-05
Abstract: An assay procedure for predicting the onset of the ovulation in a human subject. Urine samples are obtained on consecutive days and assayed for total gonadotropal alpha peptide chain content. The alpha chain content surges to indicate ovulation and the onset of the fertile period.
Patent NZ-240094-A (NZ)
Title: Preparation of carnosic acid by solvent extraction from rosemary or sage.
Inventor: AESCHBACH ROBERT
IPC: C07C51/47
Filed: 1991-10-04
Abstract: The invention relates to the use of carnosic acid for the production of a composition intended for preventing or treating cancer and for treating herpes.
Patent NZ-244479-A (NZ)
Title: Salts of sparfloxacin with polyhydroxy-monocarboxylic acids; stable solutions; pharmaceutical compositions
Inventor: CONRATH GUILLAUME
IPC: A61K31/47
Filed: 1992-09-24
Abstract: Pharmaceutical composition consisting of a stable aqueous solution of the sparfloxacin of formula: <IMAGE>  containing     - sparfloxacin, - one or more monocarboxylic polyhydroxyacids or lactone derivatives thereof, at least in a stoichiometric quantity relative to the sparfloxacin, - if necessary, an excess of monocarboxylic polyhydroxyacid or of another pharmaceutically acceptable acid intended to ensure a pH for complete solubilisation of the salt thus formed, less than or equal to 5, - optionally, an isotonising agent and/or other pharmaceutically acceptable adjuvants.
Patent NZ-286970-A (NZ)
Title: Communications handset with electrostatic screen gasket
Inventor: VILLAIN JEAN-CHRISTOPHE
IPC: H05K9/00
Filed: 1996-07-10
Abstract: The apparatus is equipped with electrostatic protection in the form of a flat housing of an insulating material, comprising a protective layer (16) incorporated in the appts. itself and made from a conducting and an insulating layer, cut to the appropriate shape. The insulating layer is a layer of a plastic foam, such as polyurethane, and the conducting layer is of metal or metal fibres, one of which has an adhesive coating.
Patent NZ-303800-A (NZ)
Title: Olefin polymers and block polymers, preparation, use, catalysts and catalyst intermediates
Inventor: JOHNSON LYNDA KAYE
IPC: C07F11/00
Filed: 1996-01-24
Abstract: Two polyolefins: i) A polyolefin that contains about 80 to 150 branches per 1000 methylene groups.  For every 100 methyl branches, there are about 30-90 ethyl branches, 4-20 propyl branches, 15-50 butyl branches, 3-15 amyl branches and 30-140 hexyl or longer branches. ii) A polyolefin, which contains about 20 to 150 branches per 1000 methylene groups.  For every 100 methyl branches, there are about 4-20 ethyl branches, 1-12 propyl branches, 1-12 butyl branches, 1-10 amyl branches and 0-20 hexyl or longer branches. Also claimed is an ethylene homopolymer with a density of 0.86 g/ml or less, a polymer of one or more alpha-olefins of the formula CH2=CH2(CH2)aH which contains the above formula (XXV), wherein R35 is an alkyl group and R36 is an alkyl group containing two or more carbon atoms.  In addition, a polypropylene containing one or both of the above formulas (XXVII) and (XXIX), provided that, if (XXIX) is present, it has to be in a greater than or equal amount to 0.5 of (XXIX) per 1000 methylene groups, or the polymer contains at least 0.5 or more of (XXVIII) per 1000 methylene groups.
Patent NZ-308931-A (NZ)
Title: 1H-4(5)-substituted imidazole derivatives useful as a histamine H3 receptor antagonist
Inventor: PHILLIPS JAMES G
IPC: A61K31/415
Filed: 1996-05-29
Abstract: A substituted imidazole derivative or a pharmaceutically acceptable salt or hydrate thereof, has the formula (I) wherein: A is -NHCO-, -N(CH3)-CO-, -NHCH2 -, -N(CH3)-CH2 -, -CH=CH-, -COCH2-, -CH2CH2-, -CH(OH)CH2- or -CºC-; X is H, CH3, NH2, NH(CH3), N(CH3)2, OH, OCH3 or SH; R2 and R3 are independently hydrogen, methyl or ethyl; n is 0 to 6; R1 is cycloalkyl, optionally substituted phenyl, heterocyclic, decahydronaphthalene or octahydroindene or R1 and X may be taken together to denote a 5,6 or 6,6 saturated bicyclic ring structure when X is NH, O, or S. A pharmaceutical composition thereof is useful for treating allergy, inflammation, cardiovascular disease, gastrointestinal disorders, CNS disorders involving attention or cognitive disorders, CNS psychiatric and motor disorders, sleep disorders, epilepsy or hypothalamic dysfunction.
Patent NZ-328137-A (NZ)
Title: Absorbent article with a pull-out tab, to lengthen the article, positioned in a recess at one end
Inventor: OSBORN THOMAS WARD
IPC: A61F13/15
Filed: 1992-10-30
Abstract: The present invention relates to absorbent articles such as sanitary napkins worn by women. More particularly, the present invention relates to absorbent articles, such as thin sanitary napkins, that are stretchable, especially in the longitudinal direction.
Patent NZ-329514-A (NZ)
Title: Greenhouse tunnel frame construction with upright supports interconnected by side members with opposing indentations
Inventor: FREI ERNST
IPC: A01G9/16
Filed: 1998-12-14
Abstract: A greenhouse tunnel has a frame member 2 which has spaced upright supports 3, 4 interconnected by spacers 5, 6 having opposing indentations.  A removable cover is stretched over the supports and is releasably retained and tensioned by the arch element 9 extending over the cover between the supports and hooked onto the indented spacers.
Patent NZ-332148-A (NZ)
Title: Manual resetting excess flow control valve particularly for use with gas pressure regulators
Inventor: AGUIARI BRUNO
IPC: F16K15/00
Filed: 1998-09-30
Abstract: The invention concerns an excess flow valve and manual resetting for gas pressure regulators.  The valve is positioned in the regulator body in a housing (21) provided between the gas input (17) and a feed hole (18) to the regulating chamber.  It has a valve seating (22) transited by the gas flow from said entrance to said feed hole and by an axis at right angles to that of the entrance and by the fact that it includes a spherical obturator (23) placed free to move in an cavity (25) at the front of the valve seating (22).  The spherical obturator (23) is normally detached from said valve seating in order to allow it to open but with the possibility of moving towards and against said valve seating to close it should there be an excess flow of gas from the input conduit.
Patent NZ-337806-A (NZ)
Title: A denture having a base provided with a coating of resilient soft material
Inventor: DEQUEKER FRANS-ARTHUR-BENOIT
IPC: A61C13/007
Filed: 1999-09-14
Abstract: The specification describes a denture with a basal seat custom formed to accommodate a fully endented jaw. The denture is constructed of bio-compatible, form stable, hard plastics.  The base is custom formed with a rounded peripheral border limited to predetermined landmarks.  The landmarks interfere with the base seat of the jaw and articulation of the denture. The denture is best illustrated by Figure 1.
Patent NZ-500158-A (NZ)
Title: High pressure hydroforming press
Inventor: JACKEL FRED G
IPC: B21D26/02
Filed: 1998-04-16
Abstract: An apparatus for hydroforming a tubular metal blank has a die structure (12), a hydroforming fluid source, a hydraulically driven tube-end engaging structure (36), a hydraulically driven pressure intensifying structure (110), and a single hydraulic power source (22). The tube-end engaging structure (36) seals opposite ends of the tubular metal blank (T) in said die cavity and is movable to longitudinally compress the tubular metal blank (T). The tube-end engaging structure receives hydroforming fluid from said hydroforming fluid source and has a hydroforming fluid supplying outlet through which hydroforming fluid can be provided to the tubular metal blank. The hydraulically driven pressure intensifying (110) structure is movable to pressurize the hydroforming fluid provided to the interior of the tubular metal blank and thereby expand a diameter of the blank. A single hydraulic power source (22) provides the hydraulic fluid under pressure to said hydraulically driven pressure intensifying structure (110) in order to move the pressure intensifying structure (110) and thereby pressurize the hydroforming fluid provided to the interior of the tubular metal blank and expand the diameter of the tubular metal blank so that its exterior surface conforms to that of the internal die surface. The single hydraulic power source (22) also provides the hydraulic fluid under pressure to the hydraulically driven tube-end engaging structure to enable the tube-end engaging structure (36) to longitudinally compress the tubular metal blank and cause metal material of the diametrically expanded tubular blank to flow longitudinally inwardly in order to replenish a wall thickness of the diametrically expanded tubular metal blank and maintain the wall thickness thereof within a predetermined range.
Patent NZ-507832-A (NZ)
Title: Dextrin-containing composition for preventing surgical adhesions
Inventor: BROWN COLIN
IPC: A61K31/718
Filed: 1999-05-13
Abstract: A composition for preventing or reducing the incidence of  adhesions in or associated with a body cavity comprising an   aqueous   formulation  containing  the   polysaccharide dextrin  in  an  amount effective to prevent or  reduce  the incidence  of  adhesions, wherein the dextrin contains  more than  15%  of  polymer with a degree of polymerisation  (DP) greater than 12 as an osmotic agent to maintain a volume  of the  aqueous  formulation  in the  body  cavity  serving  to separate  tissue which otherwise may adhere to  each  other, and  a  method  of preventing or reducing the  incidence  of post-operative  adhesions  in  or  associated  with  a  body cavity is disclosed.
Patent NZ-508033-A (NZ)
Title: Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
Inventor: DUPLANTIER ALLEN JACOB
IPC: C07D231/06
Filed: 1999-05-31
Abstract: A compound of formula (1.0.0), wherein: A is aryl, heteroaryl, or heterocyclyl; wherein the aryl, heteroaryl, or heterocyclyl is substituted with 0 to 3 R10, or is a member selected from the group consisting of divalent radicals: -A1-NHC(=O)NH-A2-, -A1-NHC(=O)O-A2-, and -A1-NH(NCN)NH-A2-, wherein A1 and A2 are each independently selected from the group consisting of hydrogen, aryl, heteroaryl, and heterocyclyl, wherein the aryl heteroaryl or heterocyclyl is substituted with 0 to 3 R10, B is described herein, E is a single bond, -O-, -CH=CH-, or a moiety of formula (1.9.0) described herein, Y is -C(=O)-, -C(=S)-, -S(=O)2-, or -CH(Ra)-, m is an integer independently selected from 0, 1 and 2, n is an integer independently selected from 1 and 2, p is an integer independently selected from 1 and 2, and R is independently selected from the group consisting of -tetrazolyl, -C(=O)OR5,  C(=O)NHS(=O)2R6, and a moiety of formula (3.0.0) described herein. Also described is the use of the compounds of formula (1.0.0) in the manufacture of a medicament for treating or preventing an inflammatory, autoimmune or respiratory diseases by inhibiting cell adhesion and associated pathogenic processes mediated by VLA-4.
Patent NZ-510034-A (NZ)
Title: Method and apparatus to synthesize and defeat video copy protection signals
Inventor: QUAN RONALD
IPC: H04N9/79
Filed: 1999-09-01
Abstract: A method and apparatus for reducing the effects of copy protection signals in a video signal, and also for providing copy protection signals for a video signal, is disclosed. The reduction technique generally utilises a particular pulse position shifting, modulation, etc., of AGC, normal sync and/or pseudo sync pulses to increase the separation between the pulses. Various embodiments are disclosed including selective shifting of the relative positions of either the sync/pseudo sync or AGC pulses, trimming portions of the sync/pseudo sync and/or the AGC pulses and narrowing of either the sync/pseudo sync and/or the AGC pulses, all to provide the selective position separation between the sync/pseudo sync and AGC pulses. The copy protection technique includes various embodiments for dynamically varying the sync/pseudo sync and AGC pulse separation by applying a modulation of the above position shifting, trimming and/or narrowing techniques over selected time periods to cycle from the copy protection condition to the copy protection defeat condition, back to the copy protection condition.
Patent NZ-512294-A (NZ)
Title: Feed rolls with replaceable flute elements
Inventor: KUBE BURK R
IPC: B27B31/00
Filed: 2001-06-11
Abstract: Replaceable flutes 26L,26R are bolted to respective anchors 28L,28R and extend radially outwardly from these anchors. Typically, flutes 26L,26R are in "V" formation and are of narrowing radial width towards the apex of the "V".
Patent NZ-516261-A (NZ)
Title: Mag expression promoters
Inventor: KAWASAKI MASAKAZU
IPC: C07D521/00
Filed: 2000-05-25
Abstract: Compounds of formula (I), wherein: R1 is H, halogen alkyl or alkoxy, R2 and R3 are independently H or alkyl, R4 is alkyl, -COOH, -COOR5, -CONR6R7, -CH2NR6R7, -CH2OH or -CH2OR8, A is -CH(OH)-, -C(=O)- or -CH2-, and Z is =CH- or =N-. The compounds are used in the manufacture of medicaments for producing MAG expression promoters for the treatment of diseases that exhibit mainly dysmyelination or demyelination.
Patent NZ-520856-A (NZ)
Title: Endoparasitic compositions comprising cyclodepsipeptides, which are administered topically and transdermally to companion animals
Inventor: KALBE JOCHEN
IPC: A61P33/10
Filed: 2001-02-09
Abstract: Endoparasiticidal agents that can be applied topically are described. The agents contain cyclic and open-chained depsipeptides consisting of amino acids and hydroxycarboxylic acids as the components and containing between 6 and 30 ring or chain atoms. Also described is the production of these agents and to their use as endoparasiticides.
Patent NZ-522264-A (NZ)
Title: Retroviral vectors comprising an enhanced 3' transcription termination structure
Inventor: CANNON PAULA MARIE
IPC: A61K35/76
Filed: 2001-05-14
Abstract: A retroviral vector comprising: (a) a 5' long terminal repeat (LTR); (b) a 3' LTR comprising a polyadenylation signal; and (c) (i) one or several heterologous upstream enhancer (UE) sequences, and/or (ii) one or several additional copies of endogenous UE sequences operatively associated with said polyadenylation signal.